Female Cialis Soft
$ 40,00 – $ 288,00Price range: $ 40,00 through $ 288,00
Femalefil
$ 46,00 – $ 89,00Price range: $ 46,00 through $ 89,00
Female Viagra
$ 41,00 – $ 305,00Price range: $ 41,00 through $ 305,00
Female Viagra is a breakthrough medication specifically formulated to support women’s sexual health and physical responsiveness. This treatment effectively addresses hypoactive sexual desire disorder (HSDD) by helping to boost low libido and increase interest in intimacy. By focusing on the natural chemical balance in the body, the medication works to improve overall sexual arousal and satisfaction levels. Regular use can help restore a fulfilling and active intimate life, allowing women to regain confidence and enjoyment in their relationships. This solution provides a reliable way for women to manage common concerns regarding sexual drive and rediscover their physical vitality.
Active substance: Sildenafil
SKU:
Female Viagra
Categories: BestSellers, Woman's Health
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
The pharmacological agents colloquially referred to as “Female Viagra”–most notably flibanserin–belong to a distinct therapeutic category of central nervous system agents designed to manage Hypoactive Sexual Desire Disorder (HSDD) in women. Unlike phosphodiesterase-5 (PDE5) inhibitors used for male erectile dysfunction, these agents act directly on neurochemical pathways in the brain rather than peripheral vascular structures. In the United States, medications for HSDD are prescription-only pharmaceutical products that require a comprehensive evaluation by a licensed healthcare provider prior to initiation.
Proper clinical administration depends on adherence to individualized therapeutic schedules and an understanding of key safety precautions. Patients must discuss all existing medical conditions, concomitant medications, and lifestyle factors with a clinician to ensure appropriate usage and minimize adverse risks.
| Parameter | Specification |
|---|---|
| Active ingredient (INN) | Flibanserin |
| Therapeutic class | Central nervous system agent / Serotonin receptor modulator |
| Dosage form | Oral film-coated tablet |
| Route of administration | Oral |
| Prescription status | Prescription only (Rx) |
| Primary purpose | Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women |
| Storage conditions | Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) |
Clinical Overview and Pharmacological Profile
Main uses
Flibanserin is indicated for the treatment of generalized, acquired hypoactive sexual desire disorder (HSDD) in premenopausal women. Generalized HSDD is characterized by persistently low sexual desire that causes marked personal distress or interpersonal difficulty. The diagnosis applies only when the condition is not attributable to a co-existing medical or psychiatric state, severe relationship discord, or the pharmacological side effects of another substance. It is not indicated for the enhancement of sexual performance, nor is it approved for use in postmenopausal women or men.
How the drug works
The mechanism of action of flibanserin involves multifactorial modulation of central neurotransmitter systems. The active drug functions as a full agonist at postsynaptic serotonin 5-HT1A receptors and as an antagonist at 5-HT2A receptors. Additionally, it exhibits moderate affinity as a partial agonist at dopamine D4 receptors. By rebalancing central serotonergic, dopaminergic, and noradrenergic activity within the prefrontal cortex, the drug modulates neuroendocrine circuits involved in sexual motivation and response. It does not exert a direct vasodilation effect on genital vascular tissues.
What happens in the body
Following oral administration, flibanserin is rapidly absorbed, achieving mean peak plasma concentrations ($C_{max}$) within approximately 45 minutes to 1 hour under fasted conditions. Administration with food delays absorption and increases overall systemic exposure ($AUC$). The drug exhibits high plasma protein binding, estimated at approximately 98%, primarily binding to human serum albumin. Metabolism occurs predominantly in the liver, mediated primarily by the cytochrome P450 enzyme CYP3A4, with minor contributions from CYP2C19. The mean terminal elimination half-life ($t_{1/2}$) is approximately 11 hours. Inactive metabolites are excreted via urine (approximately 44%) and feces (approximately 51%).
Dosing schedule
The standard recommended dosage is 100 mg administered orally once daily. Dosing must occur exclusively at bedtime. Nighttime dosing is mandatory to mitigate the risk of daytime somnolence, central nervous system depression, transient hypotension, and syncope. If a treatment course yields no subjective improvement in sexual desire and associated distress after 8 weeks of continuous daily use, therapy should be discontinued following consultation with the prescribing clinician.
First days of treatment
During the initial days of therapy, systemic drug levels accumulate toward steady-state concentrations, which are generally achieved within 3 to 5 days of regular administration. Patients should not expect an immediate physiological response upon taking a single dose; therapeutic benefits typically develop gradually over several weeks. Early treatment phases require heightened monitoring for central nervous system sedation, daytime drowsiness, or lightheadedness upon standing.
Compatibility with other medicines
Flibanserin is extensively metabolized by hepatic enzymes, rendering its plasma concentrations highly sensitive to metabolic inhibition or induction. Concomitant administration with strong CYP3A4 inhibitors (such as ketoconazole, itraconazole, clarithromycin, or ritonavir) is contraindicated due to substantial increases in flibanserin concentration, which significantly elevates the risk of severe hypotension and syncope. Moderate CYP3A4 inhibitors (such as fluconazole, diltiazem, or erythromycin) also increase drug exposure and require careful clinical monitoring or avoidance. Co-administration with CYP3A4 inducers (such as rifampin, carbamazepine, or St. John’s wort) markedly decreases drug efficacy.
Food and alcohol interactions
Consuming alcohol in combination with flibanserin increases the risk of severe hypotension and syncope. Standard clinical guidelines state that if 1 or 2 standard alcoholic drinks are consumed, patients must wait at least 2 hours before taking their bedtime dose. If 3 or more standard drinks are consumed in an evening, the bedtime dose should be skipped entirely. Additionally, consuming high-fat meals immediately prior to dosing increases peak drug exposure and AUC, which may increase the incidence of adverse central nervous system reactions.
Adverse reactions
In controlled clinical trials, the most frequently reported adverse reactions associated with daily administration included central nervous system and gastrointestinal events. Reported incidence rates include:
- Dizziness (approximately 11%)
- Somnolence and sedation (approximately 11%)
- Nausea (approximately 10%)
- Fatigue (approximately 9%)
- Insomnia (approximately 5%)
- Dry mouth (approximately 5%)
These reactions are generally mild to moderate in intensity, though severe sedation or syncopal episodes can occur, particularly when combined with interacting substances.
Important precautions
Flibanserin is contraindicated in patients with any degree of hepatic impairment, as reduced drug clearance leads to elevated plasma levels and increased risk of severe adverse events. Caution is advised in patients with pre-existing cardiovascular conditions prone to hypotension. The safety and efficacy of flibanserin during pregnancy have not been established in adequate, well-controlled human studies. Lactating mothers should consult a physician, as excretion into human milk is expected and potential risks to nursing infants must be evaluated against maternal clinical benefit.
Red flags
Patients and caregivers should remain vigilant for symptoms indicative of severe adverse events, particularly those associated with central nervous system depression or hemodynamic compromise.
| Adverse Manifestation | Clinical Significance | Action Required |
|---|---|---|
| Loss of consciousness / Syncope | Severe hypotensive event | Seek emergency medical care immediately |
| Severe, unmanageable dizziness | Hemodynamic instability or CNS depression | Remain seated/supine; contact a physician |
| Signs of hypersensitivity (swelling, rash) | Anaphylactic or allergic reaction | Discontinue drug and seek immediate medical evaluation |
| Profound daytime somnolence | Excessive CNS depression | Refrain from driving; consult the prescriber |
Patient Guidance and Frequently Asked Questions
1. What happens if a bedtime dose is skipped?
If a patient misses a scheduled bedtime dose, that dose should be omitted entirely. The patient should not take an extra dose the following morning or double the dose the next evening. Administering the medication in the morning significantly increases the risk of daytime sedation, severe dizziness, accidental injury, and impaired motor performance. The standard regimen should simply be resumed at bedtime on the following night.
2. Is it safe to drive or operate machinery after taking this medication?
Patients should refrain from driving, operating heavy machinery, or engaging in hazardous activities for at least 6 hours after taking a dose, and until they determine how the medication affects their alertness. Because central nervous system depression, dizziness, and somnolence are recognized adverse effects, daytime impairment can occur, particularly during the initial weeks of treatment or if the dose was taken late in the night.
3. How does this drug differ fundamentally from male erectile dysfunction treatments?
Unlike medications prescribed for male erectile dysfunction, which act peripherally as phosphodiesterase type 5 (PDE5) inhibitors to increase penile blood flow on an as-needed basis, flibanserin functions centrally. It modifies neurotransmitter activity in the brain regulating mood and motivation. Furthermore, it must be taken as a continuous daily regimen rather than on an acute, pre-coital basis.
4. Can this medication be discontinued abruptly, or must it be tapered?
Flibanserin does not currently require a mandatory gradual tapering schedule upon discontinuation based on standard pharmacological data. However, any decision to stop therapy should be discussed with the prescribing physician to evaluate overall response, confirm whether a full 8-week trial was completed, and monitor for any recurring symptoms related to the underlying condition.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
50 mg ,100mg |
|---|---|
| Package |
10 pills ,20 pills ,30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Alkeran
$ 112,00 – $ 513,00Price range: $ 112,00 through $ 513,00
Active substance: Melphalan
More Details
This product has multiple variants. The options may be chosen on the product page
Careprost
$ 42,00 – $ 367,00Price range: $ 42,00 through $ 367,00
Active substance: Bimatoprost
More Details
This product has multiple variants. The options may be chosen on the product page
Conjubrook
$ 215,00 – $ 705,00Price range: $ 215,00 through $ 705,00
Active substance: Conjugated Estrogens
More Details
This product has multiple variants. The options may be chosen on the product page
Diclofenac
$ 49,00 – $ 121,00Price range: $ 49,00 through $ 121,00
Active substance: diclofenac
More Details
This product has multiple variants. The options may be chosen on the product page
Estriol
$ 64,00 – $ 137,00Price range: $ 64,00 through $ 137,00
Active substance: Estriol
More Details
This product has multiple variants. The options may be chosen on the product page
Etodolac
$ 46,00 – $ 390,00Price range: $ 46,00 through $ 390,00
Active substance: Etodolac
More Details
This product has multiple variants. The options may be chosen on the product page
Female Cialis Soft
$ 40,00 – $ 288,00Price range: $ 40,00 through $ 288,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Fertigyn HP
$ 50,00 – $ 130,00Price range: $ 50,00 through $ 130,00
Active substance: Human Chorionic Gonadotrophin
More Details
This product has multiple variants. The options may be chosen on the product page
